Abstract: Methods and systems are provided for improving user authentication and access control by a network file system service in a multi-tenant public cloud environment by receiving a request for a connection to a file system from a file system client (client), sending an identification request for identification authentication of the client to a control system, receiving a response from the control system, establishing the connection to the file system upon determining that the connection to the file system is allowed based on cloud tenant information associated with the client, receiving an attempt to access the file system from the client by a sub-user, authenticating the sub-user based on the cloud tenant information, issuing a security token including a globally unique sub-user identifier of the sub-user, and using the security token to determine access rights of the sub-user to the file system for a subsequent request.

Abstract: A method for preparing a stacked solid aluminum electrolytic capacitor is disclosed. The method includes preparation of a plurality of cores, stacking and fixing of the plurality of cores in a case and encapsulation of the case. The core is prepared through the following steps. An I-shaped aluminum foil is divided into an anode part and a cathode part by applying an insulating blocking tape, where the cathode part includes a dielectric layer, which is subjected to formation. A conductive polymer layer is formed on a surface of the cathode part, and is then impregnated with conductive colloidal graphite followed by drying to form a conductive carbon paste layer. The conductive carbon paste layer is impregnated with a conductive silver paste followed by drying to form a conductive silver paste layer. After that, a core is obtained.

Abstract: The present invention relates to a method for the manufacture of a compound of Formula I or a pharmaceutically acceptable salt, acid co-crystal, hydrate or other solvate thereof, said method comprising reacting a compound of the formula II with a compound of the formula III according to the following reaction scheme: wherein LG, A, n, m and p are as defined in the Summary of the Invention.

Abstract: This application provides a multilayer solid aluminum electrolytic capacitor and a method for preparing the same. The multilayer solid aluminum electrolytic capacitor includes a plurality of cores, a rivet, a case, and a cover plate. The cores are stacked in sequence and fastened in the case through the rivet to form a semi-finished capacitor. The semi-finished capacitor is covered by the cover plate and then sealed to form the solid aluminum electrolytic capacitor.

Abstract: This application provides a multilayer solid aluminum electrolytic capacitor and a method for preparing the same. The multilayer solid aluminum electrolytic capacitor includes a plurality of cores, a rivet, a case, and a cover plate. The cores are stacked in sequence and fastened in the case through the rivet to form a semi-finished capacitor. The semi-finished capacitor is covered by the cover plate and then sealed to form the solid aluminum electrolytic capacitor.

Abstract: The present invention relates to a detection method for determining chloride ions content in sea sand, which is performed in the steps as follows: drying sea sand to a constant weight, adding the dried sea sand to boiling deionized water, and fully stirring, standing and filtering the deionized water to obtain washed sea sand and a washed filtrate; then grinding the washed sea sand into powder, adding the powder into deionized water, fully stirring and filtering the deionized water to obtain a powder filtrate; next, taking half of the washed filtrate and half of the powder filtrate, mixing and stirring the two to prepare a mixed filtrate; and measuring the chloride ions content in each of the washed filtrate, the powder filtrate and the mixed filtrate by using a silver nitrate titration method; finally, analyzing and correcting detection results to obtain the chloride ions content in the sea sand.

Abstract: A method for preparing natural vanillin via biooxidation of 4-methylguaiacol comprises (1) activating a strain and preparing a seed culture; (2) fermenting; (3) bioconversion; (4) adsorbing and eluting; and (5) concentrating and crystallizing.

Abstract: The present invention relates to a method for the manufacture of a compound of Formula I or a pharmaceutically acceptable salt, acid co-crystal, hydrate or other solvate thereof, said method comprising reacting a compound of the formula II with a compound of the formula III according to the following reaction scheme: wherein LG, A, n, m and p are as defined in the Summary of the Invention.

Abstract: The present disclosure discloses a method for preparing natural delta-decalactone and delta-dodecalactone by bioreduction of Massoia Oil, which comprises (1) Strain activation, (2) Preparation of seed culture solution, (3) Fermentation and conversion, (4) Extraction, (5) Solvent recycle, and (6) Rectification.

Abstract: A positioning method and device, a robot and a storage medium are provided. The positioning method includes: determining first position information of the robot by a positioning part; collecting an image by a camera; and determining second position information of the robot according to the image. The first position information and the second position information are fused to obtain the positioning information of the robot.

Abstract: The application provides a plaster casting mold fabrication method for a complicated structure aluminum alloy casting with a large inner cavity and a thin wall, in which, a wax pattern is cleaned with a mixture; closed blind cavity and large plane unbeneficial to plaster mold-filling of the wax pattern are used to exhaust air by using vent holes and waterproof-breathable membranes in cooperation with each other; under pressure difference, plaster powder and mixed aqueous solution are vertically splashed and mixed in a mixing tank to reduce dust discharge; asynchronous mixing and grouting can be realized by left and right mixing tanks in an upper tank of a vacuum tank. The present application can effectively remove the surface parting agent, increase the wettability of the plaster paste and the wax pattern surface, and improve the surface finish of the casting mold.

Abstract: The application provides a plaster casting mold fabrication method for a complicated structure aluminum alloy casting with a large inner cavity and a thin wall, in which, a wax pattern is cleaned with a mixture; closed blind cavity and large plane unbeneficial to plaster mold-filling of the wax pattern are used to exhaust air by using vent holes and waterproof-breathable membranes in cooperation with each other; under pressure difference, plaster powder and mixed aqueous solution are vertically splashed and mixed in a mixing tank to reduce dust discharge; asynchronous mixing and grouting can be realized by left and right mixing tanks in an upper tank of a vacuum tank. The present application can effectively remove the surface parting agent, increase the wettability of the plaster paste and the wax pattern surface, and improve the surface finish of the casting mold.

Abstract: The present invention relates to a method of dynamic division of multi-layer control boundary of an over-saturated road network based on MFD under telematics, in an internet of vehicles environment, and according to an MFD reference database, determining traffic conditions of respective minimum units in a street network, expanding sequentially from a central key node to peripheral nodes, until a boundary of a congestion region is determined, so as to establish three control boundaries, namely those for the congestion region, a transition region and a normal region in the street network. If a street network has a plurality of congestion regions, a plurality of control boundaries can be set dynamically.

Abstract: The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.

Abstract: The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.

Abstract: The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.

Abstract: The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.

Abstract: The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.

Abstract: Provided are methods and compositions useful for the diagnosis, prognosis and treatment of hepatic cellular proliferative disorders. The methods include the modulation or analysis of hypemethylated glutathione-S-transferase nuleic acid sequence in hepatic samples and biological fluids.

Abstract: Provided are methods and compositions useful for the diagnosis, prognosis and treatment of hepatic cellular proliferative disorders. The methods include the modulation or analysis of hypemethylated glutathione-S-transferase nuleic acid sequence in hepatic samples and biological fluids.